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Abstract: An enhanced tyrosine phosphorylation of focal
adhesion kinase (FAK) is elicited during neuronal growth
cone remodeling and requires the maintenance of ago-
nist-sensitive pools of phosphatidylinositol 4,5-bisphos-
phate (PIP2). Rho family GTPases are putative regulators
of both PIP2 synthesis and growth cone remodeling, in-
cluding neurite outgrowth elicited by muscarinic cholin-
ergic receptor (mAChR) stimulation. In this study, we
investigated the interrelationships among Rho family
GTPases, PIP2 synthesis, and mAChR signaling to FAK in
SH-SY5Y neuroblastoma cells. Preincubation with Clos-
tridium difficile toxin B (Tox B), an inhibitor of Rho, Rac,
and Cdc42, attenuated mAChR-stimulated FAK and pax-
illin tyrosine phosphorylation and lysophosphatidic acid
(LPA)-induced FAK phosphorylation to a similar extent
(75% decreases at 200 pg/ml Tox B) but did not affect
mitogen-activated protein kinase activation elicited by
either phorbol ester or an mAChR agonist. In contrast,
preincubation with selective inhibitors of either Rho (C3
exoenzyme) or Rho kinase (HA-1077) resulted in 80–90%
reductions in LPA-induced FAK phosphorylation but only
40–50% decreases in mAChR-stimulated phosphoryla-
tion. Moreover, mAChR-mediated FAK phosphorylation
was significantly attenuated in cells scrape-loaded with
dominant-negative N17Cdc42 but not N17Rac1. Tox B
had little or no effect on agonist-sensitive pools of PIP2
but inhibited mAChR-driven actin cytoskeletal remodel-
ing. The results suggest that the Rho family GTPases,
Rho and Cdc42, link mAChR stimulation to increases in
FAK phosphorylation independently of effects on PIP2
synthesis. Key Words: Clostridium difficile toxin B—Clos-
tridium botulinum C3 exoenzyme—Phosphatidylinositol
4,5-bisphosphate—Actin cytoskeleton—Growth cone
remodeling.
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The signal transduction machinery that couples extra-
cellular stimuli such as neurotransmitter release to
changes in synaptic strength is presently unclear. Ty-
rosine kinase activity is a requirement for both long-term
potentiation (O’Dell et al., 1991) and long-term depres-
sion (Boxall et al., 1996), two models of synaptic plas-
ticity. Focal adhesion kinase (FAK) is a nonreceptor
protein tyrosine kinase that is highly expressed in the
central nervous system, where it is localized in part to
neuronal growth cones (Burgaya et al., 1995; Worley and
Holt, 1996). A potential role for FAK in the regulation of
synaptic plasticity has recently been reviewed (Girault
et al., 1999). In neuronal cells in culture, FAK is acti-
vated by stimuli that elicit growth cone remodeling. For
example, neurite outgrowth induced by neural cell adhe-
sion molecules (NCAMs) is associated with complex
formation between FAK, NCAM-140, and fyn tyrosine
kinase (Beggs et al., 1997). In addition, treatment of
SH-SY5Y neuroblastoma cells with either insulin-like
growth factor-I (Leventhal et al., 1997) or muscarinic
cholinergic receptor (mAChR) agonists (Ro¨sner et al.,
1995) induces neurite outgrowth and an increase in the
tyrosine phosphorylation of FAK (Leventhal et al., 1997;
Linseman et al., 1998). Given the potential role of FAK
in signaling during growth cone remodeling, it is impor-
tant to understand how the above stimuli lead to an
activation of FAK.
Small molecular weight G proteins of the Rho family
act as critical regulators of actin cytoskeletal dynamics
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(for review, see Hall, 1998), and in neuronal cells, Rho
family GTPases mediate changes in growth cone mor-
phology (Luo et al., 1996; Threadgill et al., 1997).
Kozma et al. (1997) have shown that Rac and Cdc42
facilitate neurite outgrowth elicited by mAChR stimula-
tion, whereas Rho and activators of Rho such as lyso-
phosphatidic acid (LPA) induce neurite retraction (see
also Kranenburg et al., 1999). In addition, Rho has been
implicated in FAK signaling by several G protein-
coupled receptor (GPCR) agonists (for review, see Sea-
sholtz et al., 1999), and scrape-loading cells with consti-
tutively active Rho stimulates an enhanced tyrosine
phosphorylation of FAK (Flinn and Ridley, 1996). The
mechanisms underlying Rho family G protein regulation
of the actin cytoskeleton are complex and involve mul-
tiple downstream effectors of these GTPases (for review,
see Mackay and Hall, 1998). The pathway leading from
Rho GTPases to activation of FAK is even less clear.
One way by which Rho family GTPases may be linked to
FAK signaling is via the regulation of polyphosphoino-
sitide synthesis by Rho family members (Carpenter,
1996; Ren and Schwartz, 1998). Both Rho and Rac have
been shown to regulate the synthesis of phosphatidylino-
sitol 4,5-bisphosphate (PIP2) in a cell-type specific man-
ner (Chong et al., 1994; Hartwig et al., 1995). PIP2
regulates the actin cytoskeleton as well as many actin-
associated protein–protein interactions (for review, see
Toker, 1998; Martin, 1998). Recently, we have demon-
strated a novel requirement for agonist-sensitive pools of
PIP2 in the enhanced tyrosine phosphorylation of FAK
elicited by agonists at phosphoinositide-linked receptors
such as the M3 mAChR (Linseman et al., 1999). The
focus of the current study was to examine the interrela-
tionships of Rho family G protein function, inositol lipid
synthesis, and FAK signaling by addressing two princi-
pal questions: (1) Do Rho family G proteins regulate
FAK signaling elicited by mAChR stimulation, and, if
so, (2) is this regulation dependent on a modulation of
agonist-sensitive PIP2 pools?
To address the above questions, we utilized selective
inhibitors of Rho family G protein function. Toxin B
from Clostridium difficile (Tox B) is a monoglucosyl-
transferase that selectively inhibits Rho, Rac, and Cdc42
without affecting other small molecular weight GTPases
(Just et al., 1995). In contrast, C3 exoenzyme fromC.
botulinum specifically ADP-ribosylates and inactivates
Rho (Aktories et al., 1989; Braun et al., 1989). The
results of the current study demonstrate that an increased
tyrosine phosphorylation of FAK elicited in SH-SY5Y
neuroblastoma cells by either LPA or an mAChR agonist
is significantly inhibited by Tox B. Although LPA-
induced FAK phosphorylation is equally sensitive to
inhibition by either Tox B or C3 exoenzyme, mAChR-
mediated FAK phosphorylation is much less sensitive to
inhibition by C3 exoenzyme (or to an inhibitor of Rho
kinase activity, HA-1077), suggesting the involvement
of a C3 exoenzyme-insensitive Rho family member in
the signaling pathway. This suggestion was confirmed by
the observation that scrape-loading cells with dominant-
negative N17Cdc42 (but not N17Rac1) significantly at-
tenuated the mAChR-induced FAK phosphorylation. Fi-
nally, inhibition of Rho family GTPase function by Tox
B suppressed mAChR-mediated FAK phosphorylation
and actin cytoskeletal remodeling independently of ef-
fects on mAChR-sensitive PIP2 pools. The results sug-
gest that the Rho family GTPases, Rho and Cdc42, link
mAChR stimulation to FAK phosphorylation via a




Phorbol 12-myristate 13-acetate (PMA), PD-98059, HA-
1077, and C3 exoenzyme fromC. botulinumwere obtained
from Calbiochem (San Diego, CA, U.S.A.). Wortmannin (WT),
pilocarpine (PILO), and LPA were from Sigma Chemical Co.
(St. Louis, MO, U.S.A.).N,N,N-Trimethyl-4-(2-oxo-1-pyrro-
lidinyl)-2-butyn-1-ammonium iodide (Oxo-M) was purchased
from Research Biochemicals International (Natick, MA,
U.S.A.). Tox B was a gift from Dr. Klaus Aktories (Institut fu¨r
Pharmakologie und Toxikologie, Albert-Ludwigs-Universita¨t,
Freiburg, Germany). [32P]Orthophosphoric acid (10 mCi/ml),
myo-[2-3H]inositol (1 mCi/ml), reagents for enhanced chemi-
luminescence, and peroxidase-conjugated sheep anti-mouse
IgG were purchased from Amersham Corp. (Arlington Heights,
IL, U.S.A.). [32P]NAD (2 mCi/ml) was from New England
Nuclear (Boston, MA, U.S.A.). Monoclonal antibody to phos-
photyrosine (PTyr) was obtained from Upstate Biotechnology
(Lake Placid, NY, U.S.A.). Monoclonal antibody to paxillin
was from Transduction Laboratories (Lexington, KY, U.S.A.).
Polyclonal antibody to FAK, peroxidase-conjugated goat anti-
rabbit IgG, purified glutathioneS-transferase (GST), and aga-
rose-conjugated protein A/G were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, U.S.A.). Polyclonal antibody
to the dually phosphorylated (active) forms of the extracellular
signal-regulated kinases ERK-1 and ERK-2 was purchased
from Promega (Madison, WI, U.S.A.). Rhodamine-conjugated
phalloidin was from Molecular Probes (Eugene, OR, U.S.A.).
Human recombinant GST fusion proteins of (dominant-nega-
tive) N17Rac1 and N17Cdc42 were obtained from Cytoskele-
ton (Denver, CO, U.S.A.). Tissue culture supplies were pur-
chased from Corning Glass Works (Corning, NY, U.S.A.) and
Sarstedt (Newton, NC, U.S.A.). Dulbecco’s modified Eagle’s
medium (DMEM) was obtained from GIBCO (Grand Island,
NY, U.S.A.). Fetal calf serum (FCS) was from Summit Bio-
technology (Ft. Collins, CO, U.S.A.). Human SH-SY5Y neu-
roblastoma cells were obtained from Dr. June Biedler (Sloan-
Kettering Institute, New York, NY, U.S.A.).
Cell culture conditions
Human SH-SY5Y neuroblastoma cells (passages 70–78)
were routinely grown in 75-cm2 tissue culture flasks containing
20 ml of DMEM supplemented with 10% FCS. Cells were
grown for 7–14 days at 37°C in a humidified atmosphere
consisting of 90% air and 10% CO2. Cells were subcultured
into 35-mm-diameter, six-well culture plates (Becton Dickin-
son Labware, Lincoln Park, NJ, U.S.A.) for 2–5 days before
treatment. All experiments were performed on cells that had
reached confluency, except F-actin staining, which was per-
formed on cells that were;30–50% confluent.
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Incubation conditions and immunoprecipitations
Confluent cultures of SH-SY5Y cells were preincubated for
;24 h in culture medium containing either vehicle [0.1%
bovine serum albumin (BSA) in phosphate-buffered saline
(PBS)] or Tox B at a final concentration of 50, 100, or 200
pg/ml. Following the preincubation period, cells were washed
once with 2 ml of prewarmed (37°C) treatment buffer consist-
ing of 138 mM NaCl, 6 mM KCl, 1 mM MgCl2, 1 mM CaCl2,
1 mM Na2HPO4, 5 mM NaHCO3, 5.5 mM glucose, and 20 mM
HEPES (pH 7.4) and allowed to equilibrate at 37°C in 1 ml of
treatment buffer for 20 min. Alternatively, some cultures were
preincubated for 30 min with 50mM HA-1077. Cells were then
incubated for a further 10 min with either Oxo-M, PILO, or
LPA as described in the text. Following treatment, the buffer
was aspirated and cells were rinsed once with 2 ml of ice-cold
PBS (pH 7.4) lacking calcium or magnesium. Cells were then
placed on ice and scraped into lysis buffer (200ml/well) con-
taining 20 mM HEPES (pH 7.4), 1% Triton X-100, 50 mM
NaCl, 1 mM EGTA, 5 mM b-glycerophosphate, 30 mM sodium
pyrophosphate, 100mM sodium orthovanadate, 1 mM phenyl-
methylsulfonyl fluoride, 10mg/ml aprotinin, and 10mg/ml
leupeptin. Cell debris was removed by centrifugation at 6,000
g for 3 min, and the protein concentration of the supernatant
was determined using a commercially available protein assay
kit (Pierce Chemical Co., Rockford, IL, U.S.A.). Aliquots
(;350 mg) of supernatant protein were transferred to tubes
containing either 2mg of polyclonal anti-FAK or 1mg of
monoclonal anti-paxillin. Samples were then immunoprecipi-
tated at 4°C for 16–20 h with continuous mixing. Agarose-
conjugated protein A/G (20ml) was added for an additional 4 h
with mixing. Immune complexes were pelleted by centrifuga-
tion and washed three times with ice-cold lysis buffer. The final
agarose pellet was resuspended in an equal volume of 23
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE) sample buffer, boiled for 5 min, and electropho-
resed through 7.5% polyacrylamide gels. Proteins were trans-
ferred to polyvinylidene difluoride (PVDF) membranes (Milli-
pore Corp., Bedford, MA, U.S.A.) and processed for immuno-
blot analysis.
Immunoblot analysis
Nonspecific binding sites were blocked in PBS (pH 7.4)
containing 0.1% Tween 20 (PBS-T) and 1% BSA for 1 h at
room temperature. Primary antibodies were diluted in blocking
solution (0.5–1mg/ml) and incubated with the membranes for
1 h. Excess primary antibody was removed by washing the
membranes three times in PBS-T. The blots were then incu-
bated in peroxidase-conjugated secondary antibody diluted in
PBS-T (1:10,000) for 1 h and subsequently washed three times
in PBS-T. Immunoreactive proteins were detected by enhanced
chemiluminescence. Quantitative analysis of autoluminograms
was performed by computer-assisted imaging densitometry
(MCID; Imaging Research, St. Catharines, Ontario, Canada).
Measurement of mitogen-activated protein kinase
(MAPK) activation
Confluent cultures of SH-SY5Y cells were preincubated
with either vehicle or Tox B as described above. Alternatively,
some cultures were preincubated for 10 min with 10mM
PD-98059. Following preincubation, the cells were treated for
a further 10 min with either buffer, Oxo-M (1 mM), or PMA
(100 nM). Lysates (100mg) were electrophoresed through 10%
polyacrylamide gels and immunoblotted with an antibody that
recognizes the dually phosphorylated (active) forms of ERK-1
and ERK-2.
Scrape-loading with C3 exoenzyme
Confluent dishes (6-cm diameter) of SH-SY5Y cells were
scraped into culture medium containing 12.5mg/ml C3 exoen-
zyme. Cells scraped in the presence of medium alone served as
a control. To ensure that cells that were to be treated with either
Oxo-M (or PILO) or LPA had been exposed to equivalent
scrape-loading with C3 exoenzyme, each 6-cm dish was
equally dispersed into three 35-mm-diameter wells and allowed
to incubate for;24 h at 37°C/10% CO2. Following preincu-
bation, each of the three wells was treated with either buffer,
Oxo-M or PILO (1 mM), or LPA (10mM) for 10 min. Lysates
were collected, and FAK was immunoprecipitated as described
above.
Scrape-loading with GST fusion proteins
Either GST alone or GST fusion proteins (N17Rac1 or
N17Cdc42) were scrape-loaded into cells at a concentration of
20 mg/ml essentially as described (Flinn and Ridley, 1996).
Following 30 min of preincubation, cells were treated with
either buffer or Oxo-M (1 mM) for 10 min. Lysates were
collected, and FAK was immunoprecipitated as described
above.
C3 exoenzyme-catalyzed ADP-ribosylation of
Rho proteins
In vitro ADP-ribosylation of Rho proteins in SH-SY5Y
lysates obtained from cells preincubated with either vehicle or
Tox B was accomplished by incubation for 1 h at30°C in the
presence of 1mg of C3 exoenzyme and 5mCi of [32P]NAD as
previously described (Yamamoto et al., 1993). Reactions were
terminated by boiling in SDS-PAGE sample buffer. Proteins
were electrophoresed through 12.5% polyacrylamide gels and
transferred to PVDF membranes. Incorporation of [32P]ADP-
ribose into Rho proteins was determined by phosphorimager
analysis (Cyclone Storage Phosphor System; Packard Instru-
ment Company, Meriden, CT, U.S.A.).
Measurement of phosphoinositide turnover and
[3H]inositol lipids
Confluent cultures of SH-SY5Y cells were prelabeled for
48 h in culture medium containing 10mCi/ml [3H]inositol,
followed by the addition of either vehicle (0.1% BSA in PBS)
or Tox B (200 pg/ml) and incubation for a further 24 h.
Following preincubation, cells were treated in the presence of
30 mM LiCl for 30 min at 37°C with either buffer or 1 mM
Oxo-M. Reactions were terminated by the addition of chloro-
form/methanol. The accumulation of radiolabeled inositol
phosphates in the aqueous fraction was determined as previ-
ously described (Thompson and Fisher, 1990). Lipids were
extracted from the organic fraction, and phospholipids were
separated on oxalate-impregnated TLC plates. Plates were
sprayed with EN3HANCE (New England Nuclear, Boston,
MA, U.S.A.) to visualize3H-labeled lipids, which were then
quantitated by liquid scintillation counting.
Phospholipid labeling from 32Pi
SH-SY5Y cells that had been preincubated with either ve-
hicle or Tox B for 24 h were incubated to isotopic equilibrium
at 37°C in 1 ml of phosphate-free treatment buffer containing
10 mCi/ml 32Pi for 2–4 h. The labeling solution was aspirated,
and unincorporated32Pi was removed by washing with 2 ml of
the same buffer. Some cultures were then incubated for 10 min
with WT (10 mM), and the cells were then treated for a further
10 min with either buffer or Oxo-M. Incubations were termi-
nated by rapid aspiration of the treatment solution followed by
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addition of 0.5 ml of ice-cold 5% trichloroacetic acid (TCA).
Cells were scraped into TCA on ice, transferred to glass tubes
with an additional 1 ml of 5% TCA, and allowed to precipitate
on ice for 1 h. Pellets were obtained by centrifugation at 4°C
and washed once with 2 ml of ice-cold distilled water, and the
final TCA pellet was resuspended in 0.5 ml of water. Lipids
were extracted from the pellets with acidified chloroform/
methanol as previously described (Fisher and Agranoff, 1980).
Phospholipids were then separated on oxalate-impregnated
TLC plates and quantified according to a previously published
method (Fisher et al., 1984).
Rhodamine/phalloidin staining of F-actin
SH-SY5Y cells seeded on glass coverslips were preincu-
bated for 24 h in medium containing either vehicle or Tox B
(200 pg/ml). Following preincubation, the cells were then
treated for 5 min with either buffer or Oxo-M. The treatment
solution was aspirated, and the cells were fixed for 30 min in
4% paraformaldehyde in PBS. Cells were permeabilized for 30
min in PBS containing 0.2% Triton X-100 and 5% BSA and
incubated for a further 30 min with rhodamine/phalloidin
(;100 nM final concentration) in PBS containing 2% BSA and
0.2% Triton X-100. Coverslips were adhered to slides, and cell
fluorescence was visualized using a Leitz Aristoplan epifluo-
rescence microscope.
Data analysis
Results shown represent the mean6 SEM values for the
number (n) of independent experiments performed. Statistical
differences between the means of unpaired sets of data were
evaluated using the Student’s two-tailedt test. When several
treatments were compared, one-way ANOVA followed by a
post hoc Dunnett’s test was utilized to determine significant
differences. Ap value of ,0.05 was considered statistically
significant.
RESULTS
Tox B inhibits mAChR signaling to FAK
and paxillin
Previous work by Just et al. (1994) demonstrated that
monoglucosylation of Rho proteins by Tox B results in
an inhibition of subsequent C3 exoenzyme-catalyzed
ADP-ribosylation of Rho. We utilized this assay to de-
termine the efficiency of Tox B treatment in confluent
cultures of SH-SY5Y neuroblastoma cells. Preincuba-
tion of SH-SY5Y cells with Tox B resulted in a dose-
dependent inhibition of the subsequent C3 exoenzyme-
catalyzed ADP-ribosylation of Rho in cell lysates (Fig.
1A). The IC50 for Tox B-mediated inhibition of ADP-
ribosylation was;100 pg/ml, and at the highest Tox B
concentration tested (200 pg/ml), the ADP-ribosylation
of Rho was inhibited by;80% (Fig. 1B). These results
demonstrate that Tox B efficiently enters intact SH-
SY5Y cells and interacts directly with Rho family G
proteins in those cells.
Next, we evaluated the potential of Tox B to inhibit
mAChR signaling to FAK and paxillin, a downstream
cytoskeletal substrate of FAK (Schaller and Parsons,
1995). As previously reported (Linseman et al., 1998),
incubation of SH-SY5Y cells with the mAChR agonist
Oxo-M elicited marked increases (17- to 20-fold) in the
tyrosine phosphorylation of FAK (Fig. 2A, upper panel)
and paxillin (Fig. 2A, lower panel), increases that were
dose dependently inhibited by preincubation with Tox B.
The IC50 values for Tox B-induced inhibition of FAK
and paxillin phosphorylation were both;100 pg/ml, and
at the highest Tox B concentration tested (200 pg/ml),
the agonist-stimulated phosphorylation of these proteins
was inhibited by;75% (Fig. 2B). Thus, Tox B inhibits
the mAChR-stimulated tyrosine phosphorylation of FAK
and paxillin with dose–inhibition curves that closely
parallel the dose dependency of the Tox B interaction
with Rho family G proteins.
Tox B does not affect MAPK signaling
An enhanced tyrosine phosphorylation of FAK has
been linked to activation of the Ras/MAPK cascade via
the association of FAK with the adapter protein GRB-2
(Schlaepfer et al., 1994). mAChR signaling to MAPK
occurs via a protein kinase C-dependent pathway in
SH-SY5Y cells (Offermanns et al., 1993). We analyzed
the effects of Tox B on MAPK signaling elicited follow-
ing either the stimulation of mAChRs or the addition of
phorbol ester. SH-SY5Y cells incubated with either Oxo-
M or PMA demonstrated a dramatic enhancement of
MAPK activation as indicated by increases in the dually
FIG. 1. Preincubation with Tox B inhibits the subsequent in vitro
ADP-ribosylation of Rho proteins induced by C3 exoenzyme.
Confluent cultures of SH-SY5Y cells were preincubated for ;24
h in culture medium containing either vehicle (0.1% BSA in PBS)
or the indicated concentrations of Tox B. Following incubation,
the cells were lysed and supernatants were incubated for 1 h at
30°C in the presence of C3 exoenzyme and [32P]NAD. Reactions
were terminated by the addition of SDS-PAGE sample buffer,
and aliquots containing equivalent amounts of protein were elec-
trophoresed through 12.5% polyacrylamide gels. Proteins were
transferred to PVDF, and ADP-ribosylation of Rho proteins was
assessed by phosphorimager analysis. A: Representative auto-
radiogram of ADP-ribosylated Rho proteins following in vitro
incubation with C3 exoenzyme. B: Phosphorimager analysis of
the effects of preincubation with Tox B on the subsequent ADP-
ribosylation of Rho proteins. The results are expressed as a
percentage of the ADP-ribosylation detected in cells preincu-
bated with vehicle and represent the means 6 SEM of three
independent experiments. ADP-ribosylation in the vehicle con-
trol measured 19,915 6 4,652 digital light units/mm2. *p , 0.05,
significantly different from the vehicle control.
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phosphorylated forms of ERK-1 and ERK-2 (Fig. 3,
lanes 1–3). Although MAPK activation elicited by either
of these agents was equally susceptible to inhibition by
the MAPK kinase inhibitor PD-98059 (Fig. 3, lanes 7–9),
neither was affected by preincubation with 200 pg/ml
Tox B (Fig. 3, lanes 4–6). These results demonstrate that
the FAK and MAPK signaling pathways elicited by
mAChR activation are clearly distinct in their depen-
dence on Rho family G protein function.
Inhibition of either Rho or Rho kinase function
elicits differential effects on FAK phosphorylation
stimulated by mAChR agonists or LPA
LPA has previously been shown to signal to FAK
through a pathway involving the small molecular weight
G protein Rho (Kumagai et al., 1993). More recently,
LPA has also been shown to signal through a down-
stream effector of Rho, Rho kinase (Maekawa et al.,
1999). To determine if mAChR activation signals to
FAK via a similar pathway, we utilized selective inhib-
itors of either Rho function (C3 exoenzyme fromC.
botulinum) or Rho kinase activity (HA-1077; Uehata
et al., 1997). We have previously shown that C3 exoen-
zyme treatment of intact SH-SY5Y cells had only a
limited effect on mAChR-induced FAK phosphorylation
(Linseman et al., 1998). However, interpretation of this
latter result was complicated by the fact that C3 exoen-
zyme did not readily enter intact SH-SY5Y cells, as
indicated by a partial (;35%) ADP-ribosylation of Rho
proteins (Linseman et al., 1998). In an effort to circum-
vent this problem, SH-SY5Y cells were scrape-loaded
with C3 exoenzyme and the effects on Oxo-M- or LPA-
stimulated FAK phosphorylation were assessed. Scrape-
loading SH-SY5Y cells with C3 exoenzyme resulted in a
51 6 8% ADP-ribosylation of Rho proteins (n5 3, p
5 0.05). Preincubation with C3 exoenzyme significantly
blocked the LPA-induced tyrosine phosphorylation of
FAK by ;80% (Fig. 4A, upper panel), a result consistent
with the level of inhibition observed following Tox B
pretreatment (Fig. 4B). In contrast, cells scrape-loaded
with C3 exoenzyme responded to Oxo-M with an in-
crease in FAK phosphorylation that was only partially
blunted by;40% (Fig. 4A, upper panel) as compared
with the 75% decrease observed with Tox B (Fig. 4B). A
similar differential effect was also observed in cells
preincubated with the Rho kinase inhibitor HA-1077.
Whereas LPA-induced FAK phosphorylation was inhib-
ited by ;90% by HA-1077, Oxo-M-stimulated FAK
phosphorylation was only partially attenuated by;50%
(Fig. 4A, lower panel, and B).
To verify that the differential effects observed were
not due to differences in the magnitude of FAK phos-
phorylation elicited by Oxo-M versus LPA, we assessed
the effects of C3 exoenzyme and HA-1077 on FAK
phosphorylation elicited by either LPA or a partial
mAChR agonist, PILO. PILO elicited an increase in the
tyrosine phosphorylation of FAK that was equivalent to
that induced by LPA (Fig. 5). However, preincubation
with either C3 exoenzyme (Fig. 5, upper panel) or HA-
1077 (Fig. 5, lower panel) inhibited LPA-induced FAK
phosphorylation to a greater extent than that elicited by
PILO. Collectively, the above data suggest that the LPA
receptor signals to FAK principally through a Rho/Rho
FIG. 3. Tox B has no effect on MAPK activation stimulated by
either Oxo-M or PMA. Confluent cultures of SH-SY5Y cells were
preincubated for ;24 h in culture medium containing either
vehicle (0.1% BSA in PBS) or Tox B (200 pg/ml). Alternatively,
some cultures were preincubated for 10 min with 10 mM PD-
98059 (PD). Cells were then treated for a further 10 min with
either buffer, Oxo-M (1 mM ), or PMA (100 nM ). Following incu-
bation, cells were scraped into lysis buffer, supernatants con-
taining 100 mg of protein were electrophoresed through 10%
polyacrylamide gels, and proteins were transferred to PVDF
membranes. The blots were probed with a polyclonal antibody
that recognizes the Tyr /Thr-dually phosphorylated (active) forms
of ERK-1 and ERK-2. The blot shown is representative of two
independent experiments that demonstrated similar results.
FIG. 2. Tox B dose-dependently inhibits the enhanced tyrosine
phosphorylation of FAK and paxillin elicited by Oxo-M. Confluent
cultures of SH-SY5Y cells were preincubated for ;24 h in culture
medium containing either vehicle (0.1% BSA in PBS) or Tox B at
the concentrations indicated. The cells were then treated for 10
min with either buffer or 1 mM Oxo-M. A: Following incubation,
cells were scraped into lysis buffer and supernatants were im-
munoprecipitated (IP) with either polyclonal anti-FAK (upper
panel) or monoclonal anti-paxillin (lower panel), as described in
Experimental Procedures. Immune complexes were resolved by
SDS-PAGE, transferred to PVDF membranes, and immunoblot-
ted (IB) for PTyr. B: Densitometric analysis of agonist-induced
FAK and paxillin phosphorylation following preincubation with
Tox B was performed. The results are expressed as a percent-
age of the net agonist-induced increase in either FAK or paxillin
phosphorylation observed in cells preincubated with vehicle and
represent the means 6 SEM of three independent experiments.
Oxo-M addition increased the tyrosine phosphorylation of FAK
in vehicle-pretreated cells from 0.04 6 0.01 to 0.68 6 0.15 O.D.
unit and increased paxillin phosphorylation from 0.03 6 0.01 to
0.60 6 0.16 O.D. unit. *p , 0.05, significantly different from the
vehicle control.
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kinase-dependent pathway, but that mAChR signaling to
FAK may require Rho/Rho kinase as well as another
small molecular weight G protein that is Tox B-sensitive
but C3 exoenzyme-insensitive.
Inhibition of Cdc42 function attenuates mAChR
signaling to FAK
Both Rac and Cdc42 fit the criteria of Tox B-sensitive
but C3 exoenzyme-insensitive. To determine if either of
these small GTPases is involved in mAChR signaling to
FAK, dominant-negative GST fusion proteins of each of
these G proteins were scrape-loaded into cells, and the
effects on Oxo-M-induced FAK phosphorylation were
assessed. In comparison with cells scrape-loaded with
GST alone, N17Rac1 had no consistent effect on
mAChR-mediated FAK phosphorylation (Fig. 6). In con-
trast, scrape-loading cells with N17Cdc42 significantly
attenuated mAChR-induced FAK phosphorylation by 35
6 12% (Fig. 6; n5 4, p , 0.05). Thus, the M3 mAChR
signals to FAK through both Rho and Cdc42.
Tox B has little effect on phosphoinositide turnover
or agonist-sensitive pools of PIP2 in SH-SY5Y
neuroblastoma cells
The small molecular weight G proteins Rho and Rac
have each been shown to regulate the synthesis of PIP2 in
fibroblasts (Chong et al., 1994) and platelets (Hartwig
et al., 1995), respectively. Moreover, Tox B treatment
has been shown to decrease the concentration of PIP2 in
several cell lines and, as a result, to inhibit the phospho-
FIG. 5. Differential sensitivity of PILO- and LPA-stimulated FAK
phosphorylation to inhibition by either C3 exoenzyme or HA-
1077. SH-SY5Y cells were preincubated with either scrape-
loaded C3 exoenzyme (upper panel) or HA-1077 (lower panel)
exactly as described in the legend to Fig. 4. The cells were then
incubated for a further 10 min with either buffer, PILO (1 mM ), or
LPA (10 mM ). FAK immune complexes were immunoblotted (IB)
for PTyr. IP, immunoprecipitated.
FIG. 6. Effects of scrape-loaded GST–N17Rac1 and GST–
N17Cdc42 on mAChR-mediated FAK phosphorylation. A: Con-
fluent cultures of SH-SY5Y cells were scrape-loaded with either
GST alone, GST–N17Rac1, or GST–N17Cdc42 (each at a con-
centration of 20 mg/ml), as described in Experimental Proce-
dures. After 30 min of preincubation, the cells were incubated for
a further 10 min with either buffer or 1 mM Oxo-M. Cells were
homogenized in lysis buffer, and supernatants were immunopre-
cipitated (IP) with polyclonal anti-FAK. Immune complexes were
resolved by SDS-PAGE, transferred to PVDF, and immunoblot-
ted (IB) for PTyr. B: Densitometric analysis of FAK tyrosine
phosphorylation was performed. The results are expressed as a
percentage of the net increase in FAK phosphorylation induced
by Oxo-M in cells scrape-loaded with GST alone and represent
the means 6 SEM of four independent experiments. Addition of
Oxo-M increased the tyrosine phosphorylation of FAK in GST
control cells from 0.18 6 0.06 to 0.66 6 0.07 O.D. unit. *p
, 0.05, significantly different from the GST control.
FIG. 4. Differential effects of scrape-loaded C3 exoenzyme and
the Rho kinase inhibitor HA-1077 on the enhanced tyrosine
phosphorylation of FAK elicited by Oxo-M and LPA. A: Confluent
cultures of SH-SY5Y cells were either scrape-loaded with C3
exoenzyme (12.5 mg/ml) (upper panel) or preincubated with 50
mM HA-1077 (HA) (lower panel), as described in Experimental
Procedures. Following either scrape-loading with C3 exoenzyme
(24 h) or preincubation with HA-1077 (30 min), the cells were
treated for a further 10 min with either buffer, Oxo-M (1 mM ), or
LPA (10 mM ). Cells were scraped into lysis buffer, and superna-
tants were immunoprecipitated (IP) with polyclonal anti-FAK, as
described in Experimental Procedures. Immune complexes were
resolved by SDS-PAGE, transferred to PVDF membranes, and
immunoblotted (IB) for PTyr. B: Densitometric analysis of FAK
tyrosine phosphorylation was performed. The results are ex-
pressed as a percentage of the net increase in FAK phosphor-
ylation induced by each agent in the absence of either C3
exoenzyme or HA-1077 and represent the means 6 SEM of
three independent experiments. The results obtained in cells
preincubated for 24 h with 200 pg/ml Tox B are also shown for
comparison. Addition of Oxo-M or LPA increased the tyrosine
phosphorylation of FAK in vehicle (VEH) control cells from 0.06
6 0.02 to 0.55 6 0.13 or 0.29 6 0.10 O.D. unit, respectively. *p
, 0.05, **p , 0.01, significantly different from the control.
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lipase C-dependent generation of inositol phosphates in
these cells (Schmidt et al., 1996; Zhang et al., 1996;
Rümenapp et al., 1998). Given the dependence of
mAChR-stimulated FAK phosphorylation on agonist-
sensitive pools of PIP2 (Linseman et al., 1999) and Rho
family G proteins (see above), it was important to deter-
mine if Rho family G proteins are critical regulators of
PIP2 synthesis in SH-SY5Y cells. First, we analyzed the
effects of preincubation with Tox B on inositol lipid
concentrations and Oxo-M-stimulated phosphoinositide
turnover in [3H]inositol-prelabeled SH-SY5Y cells. Tox
B, at the same concentrations that significantly inhibited
mAChR signaling to FAK and paxillin, had no signifi-
cant effect on the concentrations of either phosphatidyl-
inositol (PI), phosphatidylinositol 4-phosphate (PIP), or
PIP2 under basal conditions (Fig. 7A).Furthermore, pre-
incubation with Tox B had little effect on the agonist-
stimulated production of3H-inositol phosphates (20%
inhibition at 200 pg/ml; Fig. 7B). This small decrease in
the release of inositol phosphates observed at the highest
concentration of Tox B was correlated with a small but
significant (p , 0.05) decrease in [3H]PIP2 (61 6 1% of
control; n5 3) compared with cells treated with agonist
alone (816 5% of control; n5 3). This latter result
suggests that there may be some Rho GTPase-dependent
regulation of inositol lipid synthesis that occurs in re-
sponse to agonist challenge.
To further address this possibility, we next investi-
gated if Tox B may have a selective effect on agonist-
sensitive pools of inositol lipids by comparing the effects
of Tox B on 32P-lipid labeling with those observed with
WT at a concentration (10mM) that inhibits phosphati-
dylinositol 4-kinase activity and, as a consequence,
blocks phosphoinositide turnover in this cell line (Lin-
seman et al., 1998; Sorensen et al., 1998; Willars et al.,
1998). As previously described (Linseman et al., 1999),
Oxo-M stimulation of32P-prelabeled SH-SY5Y cells for
10 min results in an;50% reduction in the labeling of
[32P]PIP2 (Fig. 8A) and a 250% increase in [
32P]phos-
phatidic acid ([32P]PA) (Fig. 8B). Preincubation with
WT significantly potentiated the agonist-induced de-
crease in [32P]PIP2 due to its ability to block phospho-
inositide resynthesis (Fig. 8A). As a result of the deple-
tion of PIP2 pools, WT pretreatment also resulted in a
profound inhibition of the agonist-stimulated production
of [32P]PA (Fig. 8B). In marked contrast to the pro-
nounced effects on phosphoinositide turnover observed
with WT, Tox B had no significant effects on either the
agonist-driven decrease in [32P]PIP2 (Fig. 8A) or the
increase in [32P]PA (Fig. 8B). Taken collectively, the
above results suggest that in the SH-SY5Y cell line, Rho
family G proteins play only a minor role, if any, in the
regulation of mAChR-sensitive inositol lipid pools.
Tox B inhibits mAChR-mediated remodeling of
the actin cytoskeleton
Rho family G proteins regulate the dynamics of the
actin cytoskeleton (Hall, 1998) including neuronal
growth cone remodeling (Threadgill et al., 1997).
Moreover, Tox B treatment has been shown to disrupt
the actin cytoskeleton (Just et al., 1995). Given that
mAChR signaling to FAK is dependent on an intact
actin cytoskeleton (Linseman et al., 1998), we analyzed
the effects of preincubation with Tox B on mAChR-
mediated cytoskeletal remodeling in SH-SY5Y cells. As
previously reported (Ro¨sner et al., 1995), incubation of
SH-SY5Y neuroblastoma cells with an mAChR agonist
elicits the rapid formation of large lamellipodia and
prominent membrane ruffles (Fig. 9A and B). In addi-
tion, we also observed an agonist-induced increase in the
FIG. 7. Tox B has minimal effects on [3H]inositol lipid labeling
and mAChR-stimulated phosphoinositide turnover in SH-SY5Y
neuroblastoma cells. Confluent flasks of SH-SY5Y cells were
prelabeled with myo-[2-3H]inositol for 48 h followed by a further
24-h incubation in culture medium containing [3H]inositol and
either vehicle (0.1% BSA in PBS) or the indicated concentrations
of Tox B. A: Following incubation, lipids from a total of ;1 mg of
cell protein per sample were extracted and separated by TLC,
and the radioactivity incorporated into PI, PIP, and PIP2 was
quantified. The results are expressed as a percentage of the
label incorporated into lipid extracted from cells treated with
vehicle and represent the means 6 SEM of three independent
experiments. The total amount of [3H]inositol incorporated into
lipids extracted from vehicle-treated cells was 585,551
6 34,524, 10,240 6 759, and 3,481 6 322 dpm/mg of protein for
PI, PIP, and PIP2, respectively. B: [3H]Inositol-prelabeled cells
were preincubated with either vehicle or Tox B as described
above and then treated with either buffer or Oxo-M (1 mM ) for 30
min in the presence of 30 mM LiCl. The agonist-stimulated
production of 3H-inositol phosphates was analyzed as described
in Experimental Procedures. The results are expressed as a
percentage of the inositol phosphates released from vehicle-
pretreated cells following agonist stimulation and represent the
means 6 SEM of three independent experiments, each per-
formed in triplicate. In vehicle-pretreated cells, Oxo-M addition
stimulated a 54.8 6 0.9-fold increase in inositol phosphate pro-
duction over the basal level. *p , 0.05, significantly different
from the control.
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apparent thickness and number of actin stress fibers (Fig.
9A and B). Preincubation with Tox B induced a disrup-
tion of the actin cytoskeleton and cell rounding (Fig. 9C).
Tox B also inhibited the agonist-driven changes in actin
cytoskeletal structure (Fig. 9D). These results suggest
that Rho family G proteins act as critical regulators of
actin cytoskeletal integrity in SH-SY5Y neuroblastoma
cells.
DISCUSSION
Previous work has demonstrated a requirement for
Rho in signaling from several phosphoinositide-linked
GPCRs to FAK, including receptors for bombesin and
endothelin (Rankin et al., 1994) and sphingolipids
(Seufferlein and Rozengurt, 1995). However, a role for
Rho GTPases in mAChR signaling to FAK has not
previously been demonstrated (see Seasholtz et al.,
1999). In the current study, we utilized highly selective
inhibitors of Rho family GTPase function to demonstrate
a requirement for these small molecular weight G pro-
teins in mAChR signaling to FAK. Preincubation withC.
difficile Tox B, at concentrations that effectively altered
Rho family G proteins in intact SH-SY5Y neuroblastoma
cells (Fig. 1), significantly inhibited mAChR-mediated
increases in the tyrosine phosphorylation of both FAK
and paxillin (Fig. 2). The inhibitory effects of Tox B
showed selectivity for agonist-stimulated FAK and pax-
illin phosphorylation, as mAChR- or PKC-mediated
MAPK activation was unaffected (Fig. 3). In addition,
SH-SY5Y cells preincubated with eitherC. botulinum
C3 exoenzyme or the Rho kinase inhibitor HA-1077 also
showed a partial inhibition of mAChR-stimulated FAK
phosphorylation (Figs. 4 and 5). Finally, scrape-loading
cells with dominant-negative N17Cdc42 significantly
attenuated mAChR-mediated FAK phosphorylation
(Fig. 6).
Although both Tox B and C3 exoenzyme have the
potential to significantly disrupt actin cytoskeletal struc-
ture (see Fig. 9 and Seufferlein and Rozengurt, 1995,
respectively), the inhibitory effects of these agents on
mAChR-mediated FAK phosphorylation are likely to
occur upstream of this gross effect. mAChRs have been
shown to signal to both Rho (Keller et al., 1997) and
Rac/Cdc42 (Kozma et al., 1997). Furthermore, scrape-
loading cells with constitutively active Rho has been
shown to stimulate an increase in FAK phosphorylation
(Flinn and Ridley, 1996). These results suggest a signal-
ing cascade in which mAChR stimulation leads to the
activation of Rho family GTPases, which in turn elicit
changes in actin cytoskeletal structure and FAK phos-
phorylation. Therefore, inhibition of Rho family GTPase
function with either Tox B or C3 exoenzyme produces
inhibitory effects on multiple downstream elements of
this signaling pathway (i.e., both an inhibition of FAK
phosphorylation and a disruption of the actin cytoskele-
ton). In addition, it should also be noted that we observed
a significant attenuation of mAChR-mediated FAK phos-
phorylation in cells scrape-loaded with dominant-nega-
tive Cdc42 (see Fig. 6). This latter agent has been shown
to have no gross effects on actin cytoskeletal integrity
but rather specifically inhibits the formation of filopodia
(Kozma et al., 1995). Thus, the above results are the first
to implicate the Rho family GTPases, Rho and Cdc42, in
mAChR signaling to FAK.
Although the enhanced tyrosine phosphorylation of
FAK elicited by LPA was equally susceptible to inhibi-
tion by either Tox B (an inhibitor of Rho, Rac, andCdc42)
or C3 exoenzyme (a specific inhibitor of Rho), mAChR-
stimulated FAK phosphorylation was much more sensi-
tive to inhibition by Tox B than C3 exoenzyme (Fig. 4B).
Furthermore, LPA- and mAChR-stimulated FAK phos-
phorylation also showed a differential sensitivity to in-
hibition by the Rho kinase inhibitor HA-1077, which,
like C3 exoenzyme, only partially inhibited mAChR-
induced FAK phosphorylation (Fig. 4B). Similar differ-
ential effects were observed whether the LPA-induced
FAK phosphorylation was compared with that stimulated
by a full mAChR agonist (Fig. 4) or a partial mAChR
FIG. 8. Comparison of Tox B and WT effects on Oxo-M-stimu-
lated phosphoinositide turnover in 32P-prelabeled SH-SY5Y
cells. Confluent cultures of SH-SY5Y cells were preincubated for
;24 h in culture medium containing either vehicle (VEH; 0.1%
BSA in PBS) or Tox B (200 pg/ml). Cells were then labeled for
2–4 h with 32Pi as described in Experimental Procedures. Fol-
lowing labeling, some cultures were preincubated for 10 min
with 10 mM WT, and the cells were then treated for a further 10
min with either buffer or Oxo-M (1 mM ). Incubations were ter-
minated by aspiration of the treatment solution and rapid addi-
tion of TCA. Lipids were then extracted and separated by TLC,
and the radioactivity incorporated into PIP2 (A) and PA (B) was
quantified. The results are expressed as a percentage of the
label incorporated into lipid extracted from cells treated with
buffer and represent the means 6 SEM of three independent
experiments, each performed in duplicate. **p , 0.01, signifi-
cantly different from Oxo-M 1 vehicle.
J. Neurochem., Vol. 74, No. 5, 2000
2017RHO AND Cdc42 REGULATE mAChR SIGNALING TO FAK
agonist (Fig. 5). These data suggested that Rho and its
downstream effectors may not be the only small molec-
ular weight G protein signaling cascade capable of cou-
pling receptor activation to FAK phosphorylation. This
suggestion was confirmed by the observation that
N17Cdc42, but not N17Rac1, significantly attenuated
mAChR-stimulated FAK phosphorylation (Fig. 6). This
result is in agreement with a previous study in fibroblasts
that showed that scrape-loading of constitutively active
Rho, but not Rac, increased the tyrosine phosphorylation
of FAK (Flinn and Ridley, 1996). Moreover, a recent
report has described a novel signaling pathway linking
Cdc42 activation to the tyrosine phosphorylation of
p130Cas, a putative downstream substrate of FAK (Eisen-
mann et al., 1999). Our observation that Cdc42 regulates
mAChR signaling to FAK is consistent with this latter
finding.
We have previously demonstrated that an increased
tyrosine phosphorylation of FAK elicited by a mechanis-
tically diverse array of stimuli requires the maintenance
of agonist-sensitive pools of PIP2 (Linseman et al.,
1999). Other researchers have shown that PIP2 synthesis
is regulated by Rho family GTPases (Carpenter, 1996;
Ren and Schwartz, 1998), although the particular Rho
family member involved is probably cell type-specific
(Chong et al., 1994; Hartwig et al., 1995). An unexpected
result to emanate from the present study is the observa-
tion that inhibition of Rho family G protein function with
Tox B significantly attenuates FAK signaling in SH-
SY5Y neuroblastoma cells without effectively altering
PIP2 synthesis or agonist-stimulated phosphoinositide
turnover (see Figs. 7 and 8). This finding is in contrast to
results obtained in either HEK cells stably transfected
with the M3 mAChR (Schmidt et al., 1996; Ru¨menapp
et al., 1998) or N1E-115 mouse neuroblastoma cells
(Zhang et al., 1996) in which Tox B treatment selectively
decreased PIP2 concentrations and significantly inhibited
agonist-stimulated phosphoinositide turnover. The dif-
ferences observed between these latter studies and the
present investigation may reflect differences in the iso-
forms of the phosphoinositide kinases expressed in each
cell type and whether or not they are under equivalent
regulation by Rho family GTPases. Although the results
obtained with Tox B in the present study provide addi-
tional evidence that regulation of inositol lipid synthesis
by the Rho family G proteins is cell type-specific, more
importantly they effectively dissociate the Rho GTPase-
dependent regulation of PIP2 synthesis from the Rho
GTPase-dependent regulation of FAK signaling. More-
over, agonist-stimulated actin cytoskeletal remodeling
was also inhibited by Tox B at concentrations that had
little to no effect on inositol lipid synthesis (Fig. 9).
Although we cannot exclude the possibility that a small,
highly compartmentalized lipid pool under the regulation
of Rho GTPases modulates the actin cytoskeleton, the
above results suggest that the ability of Rho family G
FIG. 9. Effects of Tox B on mAChR-
stimulated remodeling of the actin cy-
toskeleton. SH-SY5Y cells were preincu-
bated for ;24 h in culture medium con-
taining either vehicle (0.1% BSA in PBS)
(A and B) or 200 pg/ml Tox B (C and D).
The cells were then treated for 5 min with
either buffer (A and C) or 1 mM Oxo-M (B
and D). Following treatment, the cells
were fixed with paraformaldehyde and
permeabilized with Triton X-100, and F-
actin was stained with rhodamine/phal-
loidin, as described in Experimental
Procedures. The images shown are rep-
resentative of two independent experi-
ments that demonstrated similar results.
In B, the thin arrow indicates a lamelli-
podium and the wide arrow points to a
membrane ruffle. Bar 5 10 mm.
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proteins to effect changes in the actin cytoskeleton via a
modulation of PIP2 synthesis, as previously demon-
strated in platelets (Hartwig et al., 1995), may not be a
principal mechanism for cytoskeletal remodeling in other
cell types.
In summary, we have shown that the Rho family G
proteins, Rho and Cdc42, are both required for mAChR
signaling to FAK in SH-SY5Y neuroblastoma cells. Al-
though agonist-sensitive pools of PIP2 are also required
for mAChR signaling to FAK, this prerequisite is inde-
pendent of regulation by Rho family GTPases. The re-
sults suggest that there are several independent regula-
tory pathways that are each capable of coupling receptor
activation to changes in growth cone remodeling and
FAK activation in neuronal cells.
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